News Focus
News Focus
Post# of 257484
Next 10
Followers 64
Posts 11879
Boards Moderated 0
Alias Born 07/16/2006

Re: CT post# 227033

Friday, 11/22/2019 9:16:04 AM

Friday, November 22, 2019 9:16:04 AM

Post# of 257484
CT

It's a small field, there's only 77 drugs looking for a piece of the pie. Lolol

OCALIVA INTERCEPT
ELAFIBRANOR GENFIT
CENICRIVIROC ALLERGAN
RESMETIROM MADRIGAL
ARAMCHOL GALMED
BELAPECTIN GALECTIN
IMM124E IMMURON
FIRSOCOSTAT GILEAD
LANIFIBRANOR INVENTIVA
CILOFEXOR GILEAD
PLX_065 POXEL
MSDC_0602 CIRIUS_THERAPEUTICS
PF_05221304 PFIZER
SEMAGLUTIDE NOVONORDISK
TIPELUKAST MEDICINOVA
TROPIFEXOR NOVARTIS
SAROGLITAZAR ZYDUS
DF102 AFIMMUNE
NGM282 NGMBioPHARM
VK2809 VIKING
LMB763 NOVARTIS
BI_1467335 Boehringer_Ingelheim
NITAZOXANIDE GENFIT
TESAMORELIN Theratechnologies
HTD1801 HighTideTherapeutics
SELADELPAR CYMABAY_THERAPEUTICS
TERN_101 TERNS
BMS986036 Bristol-MyersSquibb
EDP_305 ENANTA
EYP001 ENYOPHARMA
ISOSABUTATE NORTHSEA_THERAPEUTICS
PF_06835919 PFIZER
GRI_0621 GRIPharma
BMS_986171 Bristol-MyersSquibb
NALMEFENE TaiwanJPharmaceuticals
PF_06865571 PFIZER
LIK066 NOVARTIS
BIO89_100 89BIO
NAMODENOSON CANFITE
MT_3995 MitsubishiTanabePharma
GEMCABENE GEMPHIRE
SGM_1019 SecondGenome
FORALUMAB TIZIANA
CRV431 HepionPharmaceuticals
PXL770 POXEL
SAR425899 SANOFI
SOTAGLIFLOZIN SANOFI
ELOBIXIBAT AlbireoPharma
CER_209 CERENIS
HEPASTEM PROMETHERA
KBP_042 NORDICBIOSCIENCE
DUR928 DURECT
NGM313 Merck/NGMBio
NAMACIZUMAB BIRDROCKBIO
LPCN_1144 LIPOCINE
ND_L02_s0201 NITTODENKO
RTU_1096 SUCAMPO
BEZAFIBRATE INTERCEPT
IONIS_DGAT2Rx IONISPHARMA
INT_767 INTERCEPT
NP160 NashPharmaceuticals
NP135 NashPharmaceuticals
CM_101 ChemomAb
TERN_201 TERNS
HM15211 HanmiPharmaceutical
NC_001 NAIAPHARMA
VK0214 VIKING
BFKB8488A Genentech-ROCHE
NV556 NeuroVivePharmaceuticalAB
AZD2693 IONISPHARMA_ASTRAZENECA
SP_1373 SPITFIRE_PHARMA
RLBN1127 ACQUIST
RYI_018 CREATIVEBIOLAB
NVP022 NeuroVivePharmaceuticalAB
GKT_137831 GENKYOTEC
CB4209-CB4211 CohBar
VPR_423 VisionaryPharmaceuticals

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today